Company intelligence / Profile preview

Nobell Foods

San Francisco, California, USA

Ownership: Private
Employees: ~58
Development stage: Other

Overview

Nobell Foods (operated by Alpine Bio) is developing animal-free cheese by expressing cow-derived casein proteins in genetically modified soybeans using molecular farming. Their technology addresses the functional and sensory shortcomings of current plant-based cheeses, aiming for taste, texture, and price parity with traditional dairy. The company has secured multiple US patents and is preparing for public tastings, with a market launch expected in the near future[2][5].

Modalities: Recombinant protein
Industry: Non-Drug Biotech

Partnerships

Independent Midwest soybean farmers

Beyond the preview

Go deeper on Nobell Foods.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nobell Foods.

Explore the full profile